As Yandex N V (YNDX) Shares Rose, Shareholder Kopernik Global Investors Has Cut Its Position; Mivtachim The Workers Social Insurance Fund LTD Has Lowered Its Opko Health (OPK) Stake by $3.72 Million; Market Value Declined

January 17, 2018 - By Maria Brooks

Mivtachim The Workers Social Insurance Fund Ltd decreased its stake in Opko Health Inc (OPK) by 19.34% based on its latest 2017Q3 regulatory filing with the SEC. Mivtachim The Workers Social Insurance Fund Ltd sold 619,406 shares as the company’s stock declined 24.97% while stock markets rallied. The institutional investor held 2.58M shares of the major pharmaceuticals company at the end of 2017Q3, valued at $17.73 million, down from 3.20M at the end of the previous reported quarter. Mivtachim The Workers Social Insurance Fund Ltd who had been investing in Opko Health Inc for a number of months, seems to be less bullish one the $2.57B market cap company. The stock decreased 7.63% or $0.38 during the last trading session, reaching $4.6. About 8.11 million shares traded or 88.39% up from the average. Opko Health, Inc. (NYSE:OPK) has declined 32.62% since January 17, 2017 and is downtrending. It has underperformed by 49.32% the S&P500.

David Iben decreased its stake in Yandex N V (YNDX) by 36.7% based on its latest 2017Q3 regulatory filing with the SEC. Kopernik Global Investors Llc sold 230,576 shares as the company’s stock rose 15.61% with the market. The hedge fund run by David Iben held 397,631 shares of the programming company at the end of 2017Q3, valued at $13.10M, down from 628,207 at the end of the previous reported quarter. Kopernik Global Investors Llc who had been investing in Yandex N V for a number of months, seems to be less bullish one the $11.46 billion market cap company. The stock increased 1.68% or $0.58 during the last trading session, reaching $35.18. About 2.93 million shares traded or 17.65% up from the average. Yandex N.V. (NASDAQ:YNDX) has risen 50.13% since January 17, 2017 and is uptrending. It has outperformed by 33.43% the S&P500.

Investors sentiment increased to 1.14 in Q3 2017. Its up 0.11, from 1.03 in 2017Q2. It increased, as 19 investors sold OPK shares while 58 reduced holdings. 25 funds opened positions while 63 raised stakes. 119.76 million shares or 0.19% less from 119.98 million shares in 2017Q2 were reported. Bryn Mawr Tru holds 0.01% or 19,550 shares. Financial Counselors Incorporated reported 19,465 shares. Highlander Cap Mgmt Lc holds 1,800 shares. Toronto Dominion Fincl Bank reported 26 shares. Landscape Capital Limited Liability holds 17,200 shares. Price T Rowe Assoc Md stated it has 0% of its portfolio in Opko Health, Inc. (NASDAQ:OPK). Principal accumulated 58,070 shares or 0% of the stock. Pictet Asset Mngmt Ltd holds 0% in Opko Health, Inc. (NASDAQ:OPK) or 187,400 shares. Ifc Fl reported 17,597 shares. Gabelli & Investment Advisers reported 0.01% of its portfolio in Opko Health, Inc. (NASDAQ:OPK). Moreover, Bnp Paribas Arbitrage has 0% invested in Opko Health, Inc. (NASDAQ:OPK). Old West Invest Management Llc holds 0.19% in Opko Health, Inc. (NASDAQ:OPK) or 51,670 shares. Smith Graham & Invest Advsrs LP has 0.43% invested in Opko Health, Inc. (NASDAQ:OPK). 10,100 were accumulated by Norris Perne French Ltd Liability Partnership Mi. Malaga Cove Cap Lc owns 11,175 shares for 0.04% of their portfolio.

Analysts await Opko Health, Inc. (NASDAQ:OPK) to report earnings on March, 7. They expect $-0.08 earnings per share, down 100.00% or $0.04 from last year’s $-0.04 per share. After $-0.08 actual earnings per share reported by Opko Health, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Since August 16, 2017, it had 11 insider buys, and 0 sales for $3.36 million activity.

Among 11 analysts covering Opko Health (NYSE:OPK), 8 have Buy rating, 0 Sell and 3 Hold. Therefore 73% are positive. Opko Health had 19 analyst reports since August 11, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, November 8 by Cantor Fitzgerald. The stock of Opko Health, Inc. (NASDAQ:OPK) has “Buy” rating given on Friday, June 3 by Standpoint Research. The stock has “Buy” rating by Laidlaw on Wednesday, August 12. As per Thursday, September 14, the company rating was downgraded by JP Morgan. As per Thursday, November 9, the company rating was maintained by Jefferies. The stock of Opko Health, Inc. (NASDAQ:OPK) earned “Outperform” rating by Barrington Research on Thursday, March 31. The rating was downgraded by Zacks to “Buy” on Tuesday, August 11. The firm has “Hold” rating by Jefferies given on Friday, October 20. The stock of Opko Health, Inc. (NASDAQ:OPK) has “Buy” rating given on Thursday, August 17 by Cantor Fitzgerald. As per Monday, June 12, the company rating was maintained by Jefferies.

Kopernik Global Investors Llc, which manages about $958.73M and $478.45M US Long portfolio, upped its stake in Diana Shipping Inc (NYSE:DSX) by 300,253 shares to 4.06M shares, valued at $14.75 million in 2017Q3, according to the filing. It also increased its holding in Turquoise Hill Res Ltd (NYSE:TRQ) by 664,430 shares in the quarter, for a total of 11.76M shares, and has risen its stake in Kt Corp (NYSE:KT).

Analysts await Yandex N.V. (NASDAQ:YNDX) to report earnings on February, 15. They expect $0.16 EPS, up 33.33% or $0.04 from last year’s $0.12 per share. YNDX’s profit will be $52.13 million for 54.97 P/E if the $0.16 EPS becomes a reality. After $0.13 actual EPS reported by Yandex N.V. for the previous quarter, Wall Street now forecasts 23.08% EPS growth.

Among 9 analysts covering Yandex N.V. (NASDAQ:YNDX), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. Yandex N.V. had 21 analyst reports since July 31, 2015 according to SRatingsIntel. The stock of Yandex N.V. (NASDAQ:YNDX) earned “Buy” rating by Deutsche Bank on Wednesday, October 25. The stock of Yandex N.V. (NASDAQ:YNDX) has “Neutral” rating given on Friday, May 6 by Citigroup. The rating was maintained by Deutsche Bank on Friday, July 31 with “Buy”. Goldman Sachs upgraded the stock to “Neutral” rating in Wednesday, September 16 report. The firm has “Buy” rating by Raiffeisen given on Monday, October 12. The stock of Yandex N.V. (NASDAQ:YNDX) earned “Overweight” rating by Morgan Stanley on Tuesday, November 17. On Tuesday, January 16 the stock rating was maintained by Deutsche Bank with “Buy”. The rating was downgraded by Zacks on Tuesday, August 4 to “Hold”. On Monday, March 14 the stock rating was upgraded by Citigroup to “Buy”. The firm has “Neutral” rating given on Friday, September 11 by Citigroup.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.